Search Results - "Rillo, O."

Refine Results
  1. 1
  2. 2
  3. 3

    The role of anticyclic citrullinated peptide antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica by Ceccato, F, Roverano, S, Barrionuevo, A, Rillo, O, Paira, S

    Published in Clinical rheumatology (01-11-2006)
    “…There are clinical difficulties to differentiate elderly-onset rheumatoid arthritis (EORA) patients from those with polymyalgia rheumatica (PMR), especially…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial) by Isenberg, David, Gordon, Caroline, Licu, Daiana, Copt, Samuel, Rossi, Claudia Pena, Wofsy, David

    Published in Annals of the rheumatic diseases (01-11-2015)
    “…Despite advances in systemic lupus erythematosus (SLE) treatment, many patients suffer from the disease and side effects. Atacicept is a fusion protein that…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Idiopathic osteoporosis during pregnancy by Rillo, O L, Di Stefano, C A, Bermudez, J, Maldonado Cocco, J A

    Published in Clinical rheumatology (01-06-1994)
    “…Among the idiopathic forms of osteoporosis, the one developing during pregnancy is the least common and scarcely studied. Poorly understood, it seems to stem…”
    Get full text
    Journal Article
  12. 12

    Tendinous and ligamentous hyperlaxity in patients receiving longterm hemodialysis by Rillo, O L, Babini, S M, Basnak, A, Wainer, E, Balbachan, E, Cocco, J A

    Published in Journal of rheumatology (01-08-1991)
    “…Chronic renal insufficiency gives rise to osteoarticular and tendinous alterations, with tendinous rupture reaching 3.6% among patients receiving hemodialysis…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial by Zimmer, Robert, Scherbarth, Hugo R, Rillo, Oscar Luis, Gomez-Reino, Juan Jesus, Muller, Sylviane

    Published in Annals of the rheumatic diseases (01-11-2013)
    “…To evaluate treatment with the peptide-based agent, Lupuzor, in a double-blind, randomised, placebo-controlled study of patients with systemic lupus…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Coexistence of diffuse idiopathic skeletal hyperostosis and ankylosing spondylitis by Rillo, O L, Scheines, E J, Moreno, C, Barreira, J C, Porrini, A A, Maldonado Cocco, J A

    Published in Clinical rheumatology (01-12-1989)
    “…To the best of our knowledge, only two patients with concurrent diffuse idiopathic skeletal hyperostosis (DISH) and ankylosing spondylitis (AS) have been…”
    Get full text
    Journal Article
  17. 17

    Cytidine deaminase in polymyalgia rheumatica and elderly onset rheumatoid arthritis by Paira, Sergio, Roverano, Susana, Rillo, Oscar, Barrionuevo, Alejandra, Mahieu, Stella, Millen, Néstor

    Published in Clinical rheumatology (01-10-2005)
    “…Serum cytidine deaminase (CD) as a marker of inflammatory disease was assessed in 44 patients and 47 controls to differentiate polymyalgia rheumatica (PMR)…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20